Williamson K. International experience of vedolizumab in primary sclerosis cholangitis and inflammatory bowel disease. PS-134.
Risicofactoren Hepatitis E ontrafeld
mei 2018 | Hepatitis
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties